

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 4.89362109 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 4.89362109 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.89362109 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.89362109 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.89362109 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.89362109 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.86855325 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.67955681 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.53244187 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.53244187 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.38873627 |
| 12 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.06970298 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.99673205 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.90081904 |
| 15 | detection of external biotic stimulus (GO:0098581) | 3.76345162 |
| 16 | positive thymic T cell selection (GO:0045059) | 3.66126577 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61031800 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.54372119 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.54026285 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.51465835 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.51465835 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 3.48497886 |
| 23 | response to muramyl dipeptide (GO:0032495) | 3.45673095 |
| 24 | detection of other organism (GO:0098543) | 3.41460246 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.35265200 |
| 26 | regulation of interferon-alpha production (GO:0032647) | 3.32650032 |
| 27 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.29712126 |
| 28 | T-helper 1 type immune response (GO:0042088) | 3.24767138 |
| 29 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.23184657 |
| 30 | negative T cell selection (GO:0043383) | 3.17520869 |
| 31 | negative thymic T cell selection (GO:0045060) | 3.16334738 |
| 32 | neutrophil mediated immunity (GO:0002446) | 3.10831570 |
| 33 | T cell migration (GO:0072678) | 3.10414679 |
| 34 | detection of biotic stimulus (GO:0009595) | 3.09907468 |
| 35 | response to host immune response (GO:0052572) | 3.06926993 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.06926993 |
| 37 | tolerance induction (GO:0002507) | 3.05629955 |
| 38 | germinal center formation (GO:0002467) | 3.05478499 |
| 39 | pinocytosis (GO:0006907) | 3.04174692 |
| 40 | regulation of T cell tolerance induction (GO:0002664) | 3.02847959 |
| 41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.01925480 |
| 42 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.00231733 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99042949 |
| 44 | response to host (GO:0075136) | 2.98815603 |
| 45 | response to host defenses (GO:0052200) | 2.98815603 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98815603 |
| 47 | response to peptidoglycan (GO:0032494) | 2.97336359 |
| 48 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97012652 |
| 49 | immunoglobulin mediated immune response (GO:0016064) | 2.96493109 |
| 50 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.96084707 |
| 51 | substrate-dependent cell migration (GO:0006929) | 2.95977270 |
| 52 | leukocyte aggregation (GO:0070486) | 2.94816360 |
| 53 | I-kappaB phosphorylation (GO:0007252) | 2.92865165 |
| 54 | * response to type I interferon (GO:0034340) | 2.91223596 |
| 55 | neutrophil activation involved in immune response (GO:0002283) | 2.90842257 |
| 56 | positive T cell selection (GO:0043368) | 2.90798529 |
| 57 | B cell receptor signaling pathway (GO:0050853) | 2.90420263 |
| 58 | NIK/NF-kappaB signaling (GO:0038061) | 2.90229799 |
| 59 | cell adhesion mediated by integrin (GO:0033627) | 2.89824098 |
| 60 | detection of bacterium (GO:0016045) | 2.88751080 |
| 61 | * type I interferon signaling pathway (GO:0060337) | 2.87527290 |
| 62 | * cellular response to type I interferon (GO:0071357) | 2.87527290 |
| 63 | myeloid leukocyte mediated immunity (GO:0002444) | 2.86450441 |
| 64 | positive regulation of antigen processing and presentation (GO:0002579) | 2.85474418 |
| 65 | positive regulation of interferon-beta production (GO:0032728) | 2.83951196 |
| 66 | thymic T cell selection (GO:0045061) | 2.83589218 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 2.81942586 |
| 68 | cellular extravasation (GO:0045123) | 2.79390096 |
| 69 | cellular response to ethanol (GO:0071361) | 2.79047359 |
| 70 | response to laminar fluid shear stress (GO:0034616) | 2.76069646 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 2.74667101 |
| 72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.73444494 |
| 73 | microglial cell activation (GO:0001774) | 2.71882430 |
| 74 | dendritic cell migration (GO:0036336) | 2.71160766 |
| 75 | positive regulation of macrophage cytokine production (GO:0060907) | 2.71129699 |
| 76 | interferon-gamma production (GO:0032609) | 2.69799930 |
| 77 | negative regulation of granulocyte differentiation (GO:0030853) | 2.69601515 |
| 78 | regulation of cholesterol storage (GO:0010885) | 2.68708772 |
| 79 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.68600505 |
| 80 | B cell homeostasis (GO:0001782) | 2.68134541 |
| 81 | regulation of B cell differentiation (GO:0045577) | 2.66225424 |
| 82 | leukocyte cell-cell adhesion (GO:0007159) | 2.65966640 |
| 83 | myeloid leukocyte activation (GO:0002274) | 2.65241819 |
| 84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.64194272 |
| 85 | detection of molecule of bacterial origin (GO:0032490) | 2.63620923 |
| 86 | defense response to protozoan (GO:0042832) | 2.63567028 |
| 87 | negative regulation of phagocytosis (GO:0050765) | 2.62059182 |
| 88 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.60795399 |
| 89 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.60452779 |
| 90 | T cell selection (GO:0045058) | 2.60428242 |
| 91 | glycosphingolipid catabolic process (GO:0046479) | 2.60350873 |
| 92 | negative regulation of interleukin-12 production (GO:0032695) | 2.59954280 |
| 93 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.59923926 |
| 94 | positive regulation of mast cell activation (GO:0033005) | 2.59565973 |
| 95 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.59337622 |
| 96 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.58712102 |
| 97 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.58566689 |
| 98 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.58084404 |
| 99 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.57463007 |
| 100 | regulation of mast cell degranulation (GO:0043304) | 2.56157954 |
| 101 | protein localization to endosome (GO:0036010) | 2.55498330 |
| 102 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.55204761 |
| 103 | regulation of macrophage cytokine production (GO:0010935) | 2.53204852 |
| 104 | response to interleukin-15 (GO:0070672) | 2.51889074 |
| 105 | macrophage activation (GO:0042116) | 2.50966735 |
| 106 | dendritic cell chemotaxis (GO:0002407) | 2.50674803 |
| 107 | regulation of antigen processing and presentation (GO:0002577) | 2.50222945 |
| 108 | regulation of mast cell activation (GO:0033003) | 2.50182992 |
| 109 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.50128509 |
| 110 | iron ion import (GO:0097286) | 2.48195864 |
| 111 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.47920598 |
| 112 | myeloid cell activation involved in immune response (GO:0002275) | 2.47675067 |
| 113 | neutrophil chemotaxis (GO:0030593) | 2.47297761 |
| 114 | modulation by symbiont of host cellular process (GO:0044068) | 2.46642881 |
| 115 | neutrophil activation (GO:0042119) | 2.45893931 |
| 116 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.44790247 |
| 117 | apoptotic cell clearance (GO:0043277) | 2.43873318 |
| 118 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.43344784 |
| 119 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.43295276 |
| 120 | myeloid dendritic cell activation (GO:0001773) | 2.42937913 |
| 121 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.42455636 |
| 122 | neutrophil migration (GO:1990266) | 2.41905754 |
| 123 | oligosaccharide catabolic process (GO:0009313) | 2.41608650 |
| 124 | regulation of response to interferon-gamma (GO:0060330) | 2.41517121 |
| 125 | hepatocyte apoptotic process (GO:0097284) | 2.41493249 |
| 126 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.40895405 |
| 127 | response to protozoan (GO:0001562) | 2.40617371 |
| 128 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.40604263 |
| 129 | T cell costimulation (GO:0031295) | 2.40229511 |
| 130 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.40025755 |
| 131 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.39836254 |
| 132 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.39685617 |
| 133 | regulation of interleukin-12 production (GO:0032655) | 2.39100734 |
| 134 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.38338126 |
| 135 | respiratory burst (GO:0045730) | 2.38142109 |
| 136 | regulation of tolerance induction (GO:0002643) | 2.35836870 |
| 137 | myeloid dendritic cell differentiation (GO:0043011) | 2.34916729 |
| 138 | * regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.34345308 |
| 139 | lymphocyte costimulation (GO:0031294) | 2.33934147 |
| 140 | germ cell migration (GO:0008354) | 2.32935461 |
| 141 | granulocyte activation (GO:0036230) | 2.32760926 |
| 142 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.32517383 |
| 143 | positive regulation of interleukin-2 production (GO:0032743) | 2.31801293 |
| 144 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.30574784 |
| 145 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.30264680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.29505260 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.78289895 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.24562998 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.24130433 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.17013314 |
| 6 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.81833872 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.46752119 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.39893477 |
| 9 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.05082141 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03883870 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.02287548 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.92278545 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91620336 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72107513 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.52258726 |
| 16 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.47942140 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46679121 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.37989268 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.37374108 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.29483623 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23746271 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18959304 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16254544 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.15280049 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12227936 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.11527409 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.06024672 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.95825574 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93589130 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.91692911 |
| 31 | * MYB_26560356_Chip-Seq_TH1_Human | 1.80628428 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.79302780 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76871217 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76285335 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.75239749 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75201213 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73934258 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.72738705 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.72562403 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68353748 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.65259518 |
| 42 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64842250 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63934276 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63527443 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62170244 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56414789 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54310383 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53661634 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52376799 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.50714795 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49385839 |
| 52 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.49082280 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45097078 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32986956 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30857528 |
| 56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30547479 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30207687 |
| 58 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26892608 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26404794 |
| 60 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24476982 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24476982 |
| 62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22336052 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22314537 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20101016 |
| 65 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.18833259 |
| 66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15136077 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14522690 |
| 68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12243197 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11243024 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11142294 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11079331 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.10430790 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07703384 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04367690 |
| 75 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03449403 |
| 76 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02683327 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02182562 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01869269 |
| 79 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01737503 |
| 80 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01737503 |
| 81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01296294 |
| 82 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00966498 |
| 83 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00694560 |
| 84 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.99137094 |
| 85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98982322 |
| 86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98474203 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98015444 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97353484 |
| 89 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96565425 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96014289 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94964515 |
| 92 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93801574 |
| 93 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93130693 |
| 94 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92970175 |
| 95 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.92734629 |
| 96 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92383374 |
| 97 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91753416 |
| 98 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.91392681 |
| 99 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.90757615 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90395259 |
| 101 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90367414 |
| 102 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90125156 |
| 103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90016285 |
| 104 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.89926179 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89797175 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89121205 |
| 107 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88683960 |
| 108 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88287441 |
| 109 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.87882231 |
| 110 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87783306 |
| 111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87711731 |
| 112 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87550910 |
| 113 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87241382 |
| 114 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87032516 |
| 115 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87015897 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86245644 |
| 117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86027299 |
| 118 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.85657052 |
| 119 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84960053 |
| 120 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84222892 |
| 121 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82814643 |
| 122 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82755023 |
| 123 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82716676 |
| 124 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.82394507 |
| 125 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81183056 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80967634 |
| 127 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.79791165 |
| 128 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.79656105 |
| 129 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79421958 |
| 130 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79294613 |
| 131 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79265361 |
| 132 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78934756 |
| 133 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78795128 |
| 134 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.78330826 |
| 135 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78317702 |
| 136 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77486132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.46616714 |
| 2 | MP0003436_decreased_susceptibility_to | 2.86547572 |
| 3 | MP0000685_abnormal_immune_system | 2.71426071 |
| 4 | MP0003303_peritoneal_inflammation | 2.64072353 |
| 5 | MP0005387_immune_system_phenotype | 2.62214565 |
| 6 | MP0001790_abnormal_immune_system | 2.62214565 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.55342342 |
| 8 | MP0005671_abnormal_response_to | 2.50700451 |
| 9 | * MP0001800_abnormal_humoral_immune | 2.49563235 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.44981282 |
| 11 | * MP0002419_abnormal_innate_immunity | 2.37425797 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.36024075 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.34247775 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.22363184 |
| 15 | * MP0009785_altered_susceptibility_to | 2.17498348 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.13353493 |
| 17 | * MP0002723_abnormal_immune_serum | 2.13018612 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.10329463 |
| 19 | * MP0005025_abnormal_response_to | 2.10106922 |
| 20 | * MP0001819_abnormal_immune_cell | 2.09392427 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.09203178 |
| 22 | MP0009278_abnormal_bone_marrow | 2.06972708 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.96313628 |
| 24 | MP0006082_CNS_inflammation | 1.94370411 |
| 25 | MP0002006_tumorigenesis | 1.92122020 |
| 26 | MP0008260_abnormal_autophagy | 1.91336286 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.90807965 |
| 28 | MP0002405_respiratory_system_inflammati | 1.89664876 |
| 29 | MP0004947_skin_inflammation | 1.88736838 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.87077913 |
| 31 | MP0003690_abnormal_glial_cell | 1.85322796 |
| 32 | MP0005076_abnormal_cell_differentiation | 1.83139780 |
| 33 | * MP0002398_abnormal_bone_marrow | 1.75342898 |
| 34 | MP0003724_increased_susceptibility_to | 1.74847332 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.73534591 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.72584220 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.72572141 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.71894447 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.65727906 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.65643427 |
| 41 | MP0004510_myositis | 1.63960370 |
| 42 | * MP0000716_abnormal_immune_system | 1.63326113 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.60323550 |
| 44 | MP0001853_heart_inflammation | 1.59961167 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.59832106 |
| 46 | * MP0003448_altered_tumor_morphology | 1.59113645 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.56756068 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.56746143 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.55212165 |
| 50 | * MP0001845_abnormal_inflammatory_respons | 1.54380925 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.47660081 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.47660081 |
| 53 | MP0002722_abnormal_immune_system | 1.45314472 |
| 54 | MP0003195_calcinosis | 1.44682813 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.43859537 |
| 56 | MP0001873_stomach_inflammation | 1.42921943 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.42417395 |
| 58 | MP0005451_abnormal_body_composition | 1.41197039 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.40233921 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.39601669 |
| 61 | MP0009840_abnormal_foam_cell | 1.37304814 |
| 62 | MP0000858_altered_metastatic_potential | 1.36273801 |
| 63 | MP0010307_abnormal_tumor_latency | 1.36105854 |
| 64 | * MP0002429_abnormal_blood_cell | 1.33558822 |
| 65 | MP0002933_joint_inflammation | 1.32416253 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.30590984 |
| 67 | MP0003045_fibrosis | 1.29683708 |
| 68 | MP0003091_abnormal_cell_migration | 1.28915701 |
| 69 | MP0000343_altered_response_to | 1.28138456 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.27214419 |
| 71 | MP0003279_aneurysm | 1.26709309 |
| 72 | MP0006054_spinal_hemorrhage | 1.25490012 |
| 73 | MP0005023_abnormal_wound_healing | 1.24681916 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.22112500 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 1.20469843 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.19977490 |
| 77 | MP0000767_abnormal_smooth_muscle | 1.19694226 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.18920010 |
| 79 | MP0003828_pulmonary_edema | 1.17937490 |
| 80 | * MP0008469_abnormal_protein_level | 1.16407280 |
| 81 | MP0009764_decreased_sensitivity_to | 1.15903281 |
| 82 | MP0000920_abnormal_myelination | 1.12311904 |
| 83 | MP0002254_reproductive_system_inflammat | 1.06280084 |
| 84 | MP0005365_abnormal_bile_salt | 1.05926840 |
| 85 | MP0005174_abnormal_tail_pigmentation | 1.05259543 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 1.00631441 |
| 87 | MP0005310_abnormal_salivary_gland | 1.00204269 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.99682543 |
| 89 | MP0000604_amyloidosis | 0.99307353 |
| 90 | MP0002009_preneoplasia | 0.99197755 |
| 91 | MP0000249_abnormal_blood_vessel | 0.98588025 |
| 92 | MP0005390_skeleton_phenotype | 0.96085261 |
| 93 | MP0001915_intracranial_hemorrhage | 0.94711107 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.93949259 |
| 95 | MP0003329_amyloid_beta_deposits | 0.93416307 |
| 96 | MP0001958_emphysema | 0.93300143 |
| 97 | MP0009763_increased_sensitivity_to | 0.90496595 |
| 98 | MP0001851_eye_inflammation | 0.87357376 |
| 99 | MP0004883_abnormal_blood_vessel | 0.85847594 |
| 100 | MP0010386_abnormal_urinary_bladder | 0.83219928 |
| 101 | MP0005164_abnormal_response_to | 0.82567872 |
| 102 | MP0001879_abnormal_lymphatic_vessel | 0.81818440 |
| 103 | MP0000609_abnormal_liver_physiology | 0.81253151 |
| 104 | MP0000015_abnormal_ear_pigmentation | 0.80242571 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80057158 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.79647841 |
| 107 | MP0008004_abnormal_stomach_pH | 0.79263595 |
| 108 | * MP0003795_abnormal_bone_structure | 0.78463799 |
| 109 | MP0002168_other_aberrant_phenotype | 0.77950509 |
| 110 | MP0002928_abnormal_bile_duct | 0.77922444 |
| 111 | MP0000371_diluted_coat_color | 0.77683054 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 0.75915699 |
| 113 | MP0003950_abnormal_plasma_membrane | 0.75876937 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.75610943 |
| 115 | MP0008874_decreased_physiological_sensi | 0.75456303 |
| 116 | MP0000490_abnormal_crypts_of | 0.74323326 |
| 117 | MP0005257_abnormal_intraocular_pressure | 0.73790292 |
| 118 | MP0005408_hypopigmentation | 0.72709233 |
| 119 | MP0005166_decreased_susceptibility_to | 0.71951366 |
| 120 | MP0000733_abnormal_muscle_development | 0.71426065 |
| 121 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.70981274 |
| 122 | MP0003075_altered_response_to | 0.68267674 |
| 123 | MP0003866_abnormal_defecation | 0.67639404 |
| 124 | MP0005165_increased_susceptibility_to | 0.66494653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.62259080 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.62259080 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.62259080 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.36854112 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.20099475 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.96180773 |
| 7 | Hematochezia (HP:0002573) | 3.94772533 |
| 8 | Spontaneous hematomas (HP:0007420) | 3.43683356 |
| 9 | Myositis (HP:0100614) | 3.35377185 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 3.34591562 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.20354056 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.19652192 |
| 13 | Keratoconjunctivitis sicca (HP:0001097) | 3.10384626 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.07764720 |
| 15 | Loss of speech (HP:0002371) | 3.06528585 |
| 16 | Recurrent viral infections (HP:0004429) | 3.01533502 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.00205394 |
| 18 | Keratoconjunctivitis (HP:0001096) | 2.90737559 |
| 19 | Pustule (HP:0200039) | 2.89264962 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 2.86594711 |
| 21 | Myocardial infarction (HP:0001658) | 2.85261331 |
| 22 | Gingivitis (HP:0000230) | 2.81685816 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 2.77869205 |
| 24 | Periodontitis (HP:0000704) | 2.75318184 |
| 25 | Cerebral aneurysm (HP:0004944) | 2.71336394 |
| 26 | Orchitis (HP:0100796) | 2.71074300 |
| 27 | Stomatitis (HP:0010280) | 2.69483185 |
| 28 | Recurrent skin infections (HP:0001581) | 2.66132356 |
| 29 | Glomerulonephritis (HP:0000099) | 2.64677797 |
| 30 | Abnormality of macrophages (HP:0004311) | 2.63623844 |
| 31 | Chronic otitis media (HP:0000389) | 2.61024431 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.50834412 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.46976201 |
| 34 | Arterial thrombosis (HP:0004420) | 2.40313385 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.40195071 |
| 36 | Optic neuritis (HP:0100653) | 2.40195071 |
| 37 | Encephalitis (HP:0002383) | 2.39926960 |
| 38 | T lymphocytopenia (HP:0005403) | 2.39252489 |
| 39 | Syringomyelia (HP:0003396) | 2.38530971 |
| 40 | Spinal cord lesions (HP:0100561) | 2.38530971 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.37925423 |
| 42 | Abnormality of T cell number (HP:0011839) | 2.37468962 |
| 43 | Amyloidosis (HP:0011034) | 2.36492139 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.36298549 |
| 45 | Complement deficiency (HP:0004431) | 2.35117686 |
| 46 | Subacute progressive viral hepatitis (HP:0006572) | 2.34751399 |
| 47 | Cellulitis (HP:0100658) | 2.31482402 |
| 48 | Colitis (HP:0002583) | 2.31276547 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.30825913 |
| 50 | Recurrent bronchitis (HP:0002837) | 2.29455328 |
| 51 | Pulmonary embolism (HP:0002204) | 2.29398016 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.28766065 |
| 53 | Eosinophilia (HP:0001880) | 2.28293493 |
| 54 | Recurrent cutaneous fungal infections (HP:0011370) | 2.28280710 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.28280710 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 2.26476528 |
| 57 | Mutism (HP:0002300) | 2.26277380 |
| 58 | Aortic aneurysm (HP:0004942) | 2.26180053 |
| 59 | Leukocytosis (HP:0001974) | 2.25449646 |
| 60 | Chest pain (HP:0100749) | 2.25255337 |
| 61 | Hyperacusis (HP:0010780) | 2.21934138 |
| 62 | Spondylolisthesis (HP:0003302) | 2.20343997 |
| 63 | Vasculitis (HP:0002633) | 2.16305998 |
| 64 | Progressive neurologic deterioration (HP:0002344) | 2.15424936 |
| 65 | Nasal polyposis (HP:0100582) | 2.13702074 |
| 66 | Gangrene (HP:0100758) | 2.12107497 |
| 67 | Meningitis (HP:0001287) | 2.11902287 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.11810097 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.11210844 |
| 70 | Mitral stenosis (HP:0001718) | 2.11153689 |
| 71 | Aortic dissection (HP:0002647) | 2.08996980 |
| 72 | Thyroiditis (HP:0100646) | 2.07677465 |
| 73 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.07092026 |
| 74 | Osteomyelitis (HP:0002754) | 2.07010885 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.06827075 |
| 76 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.06187087 |
| 77 | Short 4th metacarpal (HP:0010044) | 2.06187087 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05939284 |
| 79 | Osteolytic defects of the hand bones (HP:0009699) | 2.05939284 |
| 80 | Absent frontal sinuses (HP:0002688) | 2.04442169 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.02650050 |
| 82 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.02185261 |
| 83 | Abnormality of complement system (HP:0005339) | 2.01911949 |
| 84 | Gingival bleeding (HP:0000225) | 2.00656456 |
| 85 | Abnormality of T cells (HP:0002843) | 2.00522798 |
| 86 | Prostate neoplasm (HP:0100787) | 1.99713085 |
| 87 | Increased CSF protein (HP:0002922) | 1.98173601 |
| 88 | Nephritis (HP:0000123) | 1.98018727 |
| 89 | Joint hemorrhage (HP:0005261) | 1.97777006 |
| 90 | Fatigue (HP:0012378) | 1.97457985 |
| 91 | Disinhibition (HP:0000734) | 1.96932108 |
| 92 | Panhypogammaglobulinemia (HP:0003139) | 1.95837091 |
| 93 | Peritonitis (HP:0002586) | 1.95666494 |
| 94 | Cerebral inclusion bodies (HP:0100314) | 1.95229710 |
| 95 | Anorexia (HP:0002039) | 1.91262157 |
| 96 | Abnormality of the pericardium (HP:0001697) | 1.91116091 |
| 97 | Esophageal varix (HP:0002040) | 1.91070959 |
| 98 | Purpura (HP:0000979) | 1.90354131 |
| 99 | Episodic fever (HP:0001954) | 1.89928915 |
| 100 | Polyneuropathy (HP:0001271) | 1.89867186 |
| 101 | Increased IgM level (HP:0003496) | 1.89821657 |
| 102 | Abnormality of the fingertips (HP:0001211) | 1.88757303 |
| 103 | Abnormality of eosinophils (HP:0001879) | 1.88086969 |
| 104 | Abnormality of the endocardium (HP:0004306) | 1.87531063 |
| 105 | Mucopolysacchariduria (HP:0008155) | 1.86428502 |
| 106 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86428502 |
| 107 | Apathy (HP:0000741) | 1.86403941 |
| 108 | Thick nail (HP:0001805) | 1.86134878 |
| 109 | IgM deficiency (HP:0002850) | 1.86125932 |
| 110 | Joint swelling (HP:0001386) | 1.86042942 |
| 111 | Obstructive lung disease (HP:0006536) | 1.85829860 |
| 112 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85829860 |
| 113 | Disproportionate tall stature (HP:0001519) | 1.84593105 |
| 114 | Acne (HP:0001061) | 1.83340053 |
| 115 | Hypergammaglobulinemia (HP:0010702) | 1.83253593 |
| 116 | Increased serum ferritin (HP:0003281) | 1.83181431 |
| 117 | Granulocytopenia (HP:0001913) | 1.82935500 |
| 118 | Diminished motivation (HP:0000745) | 1.81930683 |
| 119 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81454990 |
| 120 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81454990 |
| 121 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81454990 |
| 122 | Mitral valve prolapse (HP:0001634) | 1.80993610 |
| 123 | Severe combined immunodeficiency (HP:0004430) | 1.79412537 |
| 124 | Axonal loss (HP:0003447) | 1.78426933 |
| 125 | Bicuspid aortic valve (HP:0001647) | 1.78389083 |
| 126 | Emphysema (HP:0002097) | 1.78117722 |
| 127 | Hypoplasia of the thymus (HP:0000778) | 1.77205726 |
| 128 | Agammaglobulinemia (HP:0004432) | 1.76846175 |
| 129 | Arterial tortuosity (HP:0005116) | 1.76685671 |
| 130 | Glomerulopathy (HP:0100820) | 1.75742675 |
| 131 | Hemoptysis (HP:0002105) | 1.75434356 |
| 132 | Lymphopenia (HP:0001888) | 1.75299257 |
| 133 | Urticaria (HP:0001025) | 1.74932120 |
| 134 | Vertebral compression fractures (HP:0002953) | 1.74383077 |
| 135 | Cerebral hemorrhage (HP:0001342) | 1.74375284 |
| 136 | Abnormality of the peritoneum (HP:0002585) | 1.73999471 |
| 137 | Steatorrhea (HP:0002570) | 1.73230821 |
| 138 | Polycythemia (HP:0001901) | 1.73042400 |
| 139 | Cheilitis (HP:0100825) | 1.71877458 |
| 140 | Hepatosplenomegaly (HP:0001433) | 1.71805187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.40426128 |
| 2 | MAP3K14 | 3.11614868 |
| 3 | * TYK2 | 2.70860414 |
| 4 | NEK1 | 2.60591503 |
| 5 | TBK1 | 2.46958234 |
| 6 | TXK | 2.42989632 |
| 7 | TGFBR2 | 2.37106884 |
| 8 | IKBKE | 2.33191539 |
| 9 | JAK1 | 2.22704370 |
| 10 | JAK3 | 2.17843473 |
| 11 | FGFR4 | 2.17728111 |
| 12 | ERN1 | 2.06944451 |
| 13 | KIT | 2.04621470 |
| 14 | IRAK4 | 2.00449873 |
| 15 | BLK | 1.88763742 |
| 16 | STK10 | 1.88696976 |
| 17 | CAMKK2 | 1.86517957 |
| 18 | ZAP70 | 1.85572406 |
| 19 | MAP3K10 | 1.81799687 |
| 20 | FGFR3 | 1.69459205 |
| 21 | BMPR2 | 1.67354236 |
| 22 | IRAK1 | 1.65725256 |
| 23 | CDK12 | 1.64434893 |
| 24 | FGR | 1.63886953 |
| 25 | ITK | 1.63705675 |
| 26 | EPHA3 | 1.62362557 |
| 27 | TRIB3 | 1.61977236 |
| 28 | IKBKB | 1.59865059 |
| 29 | EPHB1 | 1.57670040 |
| 30 | CSK | 1.57364975 |
| 31 | ACVR1B | 1.56976385 |
| 32 | EEF2K | 1.54249960 |
| 33 | PKN2 | 1.53868567 |
| 34 | CHUK | 1.50471317 |
| 35 | PTK6 | 1.49597643 |
| 36 | PDGFRA | 1.46796614 |
| 37 | CAMK1D | 1.40562745 |
| 38 | TTN | 1.35948805 |
| 39 | * HCK | 1.33139332 |
| 40 | SIK2 | 1.29145434 |
| 41 | LCK | 1.27900388 |
| 42 | BTK | 1.27117932 |
| 43 | CSF1R | 1.23509087 |
| 44 | IRAK3 | 1.22054934 |
| 45 | AKT3 | 1.19048356 |
| 46 | TAOK1 | 1.17348365 |
| 47 | SIK1 | 1.16782171 |
| 48 | MAP3K2 | 1.16302212 |
| 49 | GRK6 | 1.15126536 |
| 50 | RIPK1 | 1.14492579 |
| 51 | MAP2K3 | 1.12463005 |
| 52 | MARK3 | 1.11912131 |
| 53 | PDGFRB | 1.11251765 |
| 54 | SYK | 1.10409571 |
| 55 | JAK2 | 1.10383349 |
| 56 | PIM1 | 1.07301179 |
| 57 | TEC | 1.04773985 |
| 58 | CDK6 | 1.04769726 |
| 59 | RPS6KA4 | 1.00448886 |
| 60 | CLK1 | 1.00259250 |
| 61 | PRPF4B | 0.99005574 |
| 62 | KDR | 0.96883437 |
| 63 | LRRK2 | 0.96837790 |
| 64 | NEK9 | 0.95034280 |
| 65 | TNK2 | 0.93996673 |
| 66 | MAP3K1 | 0.93514461 |
| 67 | IRAK2 | 0.87966863 |
| 68 | RIPK4 | 0.87112292 |
| 69 | SCYL2 | 0.86318907 |
| 70 | KSR2 | 0.85771869 |
| 71 | CAMK1G | 0.84814901 |
| 72 | LYN | 0.84146345 |
| 73 | DDR2 | 0.82907095 |
| 74 | MAP3K12 | 0.81627658 |
| 75 | FLT3 | 0.80278182 |
| 76 | NLK | 0.80024664 |
| 77 | MOS | 0.78358563 |
| 78 | MAP3K13 | 0.77598383 |
| 79 | MAP3K11 | 0.75196330 |
| 80 | CDC42BPA | 0.74918574 |
| 81 | SGK2 | 0.74137815 |
| 82 | FER | 0.73463545 |
| 83 | STK3 | 0.73154163 |
| 84 | PAK4 | 0.71274169 |
| 85 | STK4 | 0.70926989 |
| 86 | KSR1 | 0.68468998 |
| 87 | TAOK2 | 0.67246412 |
| 88 | MAP3K5 | 0.67122448 |
| 89 | BRD4 | 0.67021255 |
| 90 | TGFBR1 | 0.66753780 |
| 91 | EGFR | 0.66498403 |
| 92 | MAP3K6 | 0.63330032 |
| 93 | MAP3K3 | 0.63078030 |
| 94 | YES1 | 0.61860708 |
| 95 | FES | 0.59641352 |
| 96 | SGK3 | 0.57560498 |
| 97 | MAPK11 | 0.55845126 |
| 98 | ABL1 | 0.55569563 |
| 99 | PDK1 | 0.55516842 |
| 100 | STK38 | 0.54970115 |
| 101 | DYRK1B | 0.54370427 |
| 102 | PRKCH | 0.54367042 |
| 103 | PIK3CG | 0.52197298 |
| 104 | CDK4 | 0.51880448 |
| 105 | PRKCQ | 0.51224003 |
| 106 | ALK | 0.50604233 |
| 107 | PAK3 | 0.50501610 |
| 108 | CDK9 | 0.50327856 |
| 109 | ROCK2 | 0.50277172 |
| 110 | MTOR | 0.49622720 |
| 111 | INSR | 0.48288238 |
| 112 | GRK7 | 0.47719116 |
| 113 | TRPM7 | 0.46432341 |
| 114 | ADRBK2 | 0.46283890 |
| 115 | PTK2B | 0.44776364 |
| 116 | PDPK1 | 0.44083409 |
| 117 | FYN | 0.42151477 |
| 118 | TAOK3 | 0.40039223 |
| 119 | FRK | 0.39671679 |
| 120 | SIK3 | 0.39456105 |
| 121 | FGFR2 | 0.39351123 |
| 122 | CAMK4 | 0.38980791 |
| 123 | MAPK7 | 0.38856371 |
| 124 | PRKD2 | 0.38525281 |
| 125 | GSK3A | 0.38104643 |
| 126 | EPHB2 | 0.37979497 |
| 127 | MATK | 0.37745208 |
| 128 | CAMKK1 | 0.36686794 |
| 129 | * IGF1R | 0.36477618 |
| 130 | PTK2 | 0.35918619 |
| 131 | MELK | 0.35754119 |
| 132 | RET | 0.34336916 |
| 133 | LATS1 | 0.34274440 |
| 134 | BMX | 0.33390934 |
| 135 | MAPKAPK2 | 0.32323891 |
| 136 | EIF2AK2 | 0.32211562 |
| 137 | RPS6KA6 | 0.31448816 |
| 138 | MAPK12 | 0.29887375 |
| 139 | MAPK4 | 0.28729251 |
| 140 | PRKD1 | 0.27371748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.71807155 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.67426411 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46204688 |
| 4 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32825958 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.29751710 |
| 6 | * Measles_Homo sapiens_hsa05162 | 2.05263961 |
| 7 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.02588903 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02076691 |
| 9 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.91185986 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79584702 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78419144 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.73187383 |
| 13 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72547289 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70429935 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67299501 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64381370 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.63495237 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.55643989 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.53477695 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51748807 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50096681 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49934302 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.49363932 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46896479 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.46366902 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45626250 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.40501005 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.39278149 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37487400 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.35332258 |
| 31 | * Influenza A_Homo sapiens_hsa05164 | 1.34689921 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32613785 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30612962 |
| 34 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.30608917 |
| 35 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28222913 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27696178 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.26187154 |
| 38 | * Hepatitis B_Homo sapiens_hsa05161 | 1.26007818 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24257820 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22919308 |
| 41 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22502191 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.21542396 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21318311 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19832156 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.18962540 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16794481 |
| 47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.14054839 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13063831 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10219761 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09260611 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08172584 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06751504 |
| 53 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00691351 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00200169 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.99818023 |
| 56 | * Hepatitis C_Homo sapiens_hsa05160 | 0.98706813 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95345099 |
| 58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.95109355 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92490750 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91866200 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.90077132 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.89652525 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88824831 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.88734164 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.84825805 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.82930719 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.81799800 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.80409289 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76658410 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76499097 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74895040 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74440403 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.74385283 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73393965 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73211938 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71803864 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71249772 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71228159 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.70683233 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67520554 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67029179 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65197726 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64847543 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63386796 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62338663 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62230906 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.62127688 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61713626 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58079218 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.58056268 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55836677 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52978793 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51492634 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51177299 |
| 95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50719759 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50514464 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50075885 |
| 98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49755479 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.46448210 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45498711 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.45128784 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.44763672 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43868548 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43309257 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43284459 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43197322 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42302294 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41949683 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41591931 |
| 110 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40436486 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.37898098 |
| 112 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.37236269 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37147148 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36780513 |
| 115 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36262307 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36166362 |
| 117 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.34207870 |
| 118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32269747 |
| 119 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30366347 |
| 120 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.28786475 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28502158 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28023954 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27590605 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26581645 |
| 125 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25060528 |

